These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15116089)
1. Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Koziczak M; Holbro T; Hynes NE Oncogene; 2004 Apr; 23(20):3501-8. PubMed ID: 15116089 [TBL] [Abstract][Full Text] [Related]
2. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019 [TBL] [Abstract][Full Text] [Related]
3. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. Bansal R; Magge S; Winkler S J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292 [TBL] [Abstract][Full Text] [Related]
4. C-erbB2, p27 and G1/S aberrations in human primary breast cancer. Lodén M; Perris F; Nielsen NH; Emdin SO; Landberg G Anticancer Res; 2003; 23(3A):2053-61. PubMed ID: 12894578 [TBL] [Abstract][Full Text] [Related]
5. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. McLeskey SW; Ding IY; Lippman ME; Kern FG Cancer Res; 1994 Jan; 54(2):523-30. PubMed ID: 7506125 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation. Giani C; Casalini P; Pupa SM; De Vecchi R; Ardini E; Colnaghi MI; Giordano A; Ménard S Oncogene; 1998 Jul; 17(4):425-32. PubMed ID: 9696035 [TBL] [Abstract][Full Text] [Related]
7. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells. Glassford J; Rabin N; Lam EW; Yong KL Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300 [TBL] [Abstract][Full Text] [Related]
8. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441 [TBL] [Abstract][Full Text] [Related]
9. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612 [TBL] [Abstract][Full Text] [Related]
10. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J; Slivova V; Sliva D Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287 [TBL] [Abstract][Full Text] [Related]
11. Focal adhesion signaling and actin stress fibers are dispensable for progression through the ongoing cell cycle. Margadant C; van Opstal A; Boonstra J J Cell Sci; 2007 Jan; 120(Pt 1):66-76. PubMed ID: 17148575 [TBL] [Abstract][Full Text] [Related]
12. 25-Methoxyhispidol A, a novel triterpenoid of Poncirus trifoliata, inhibits cell growth via the modulation of EGFR/c-Src signaling pathway in MDA-MB-231 human breast cancer cells. Chung HJ; Park EJ; Pyee Y; Hua Xu G; Lee SH; Kim YS; Lee SK Food Chem Toxicol; 2011 Nov; 49(11):2942-6. PubMed ID: 21782877 [TBL] [Abstract][Full Text] [Related]
13. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Choi EJ; Kim GH Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Swarbrick A; Akerfeldt MC; Lee CS; Sergio CM; Caldon CE; Hunter LJ; Sutherland RL; Musgrove EA Oncogene; 2005 Jan; 24(3):381-9. PubMed ID: 15489884 [TBL] [Abstract][Full Text] [Related]
15. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1. Altiok N; Mezzadra H; Patel P; Koyuturk M; Altiok S Breast Cancer Res Treat; 2008 May; 109(2):315-23. PubMed ID: 17638069 [TBL] [Abstract][Full Text] [Related]
16. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells. Xu H; Washington S; Verderame MF; Manni A Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746 [TBL] [Abstract][Full Text] [Related]
17. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway. Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181 [TBL] [Abstract][Full Text] [Related]
18. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways. Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585 [TBL] [Abstract][Full Text] [Related]
19. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652 [TBL] [Abstract][Full Text] [Related]
20. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma]. Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]